ATAI (AtaiBeckley) Net Interest Margin (Bank Only) %


ATAI AtaiBeckley Inc ATAI
56 GF Score
Price $5.27
GF Value $7.45
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is AtaiBeckley Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

ATAI
56GF Score
AtaiBeckley Inc ATAI
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is AtaiBeckley (ATAI) Overvalued in 2026?

Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued. The current stock price of $5.27 is trading 29.3% below its estimated GF Value™ of $7.45. GuruFocus considers AtaiBeckley to be Modestly Undervalued.

Key valuation signals for ATAI:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: $7.45 vs. price of $5.27 (29.3% below fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the ATAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AtaiBeckley Business Description

Other Exchanges B72:Germany
Address 250 West 34th Street, New York, NY, USA, 10119
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
56GF Score

Get the complete analysis for ATAI

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.27
Price
$7.45
GF Value